Skip to content

Effectiveness of wheat grass supplement on selected blood parameters, performance status and fatigue among cancer patients at GGSMCH, Faridkot.

An experimental study to assess the effectiveness of wheat grass supplement on selected blood parameters, performance status and fatigue among cancer patients at GGSMCH, Faridkot, Punjab.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/03/031936
Enrollment
70
Registered
2021-03-12
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 8- Other Procedures

Interventions

Intervention1: Wheat grass supplement on selected blood parameters, performance status and faigue: 1. Pre-assessment with clinical profile sheet, Multidimensional fatigue assessment scale and Karnofsk

Sponsors

Komalpreet Kaur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Suffering from cancer. 2. Adult cancer patients (18years -65years of age. 3. Taking treatment of cancer from GGSMCH, Faridkot, Punjab.

Exclusion criteria

Exclusion criteria: 1. Not willing to participate. 2. Known allergic to any wheat grass ingredient or wheat itself. 3. Physically and mentally not fit for the study.

Design outcomes

Primary

MeasureTime frame
Blood parameters (CBC and Total serum protein), performance status and fatigueTimepoint: At baseline After 3 weeks of intervention After 6 weeks of intervention

Secondary

MeasureTime frame
There will be significant difference between Intervenational and conventional group.Timepoint: Interventional group will show positive outcome than the conventional group within specific unit of time

Countries

India

Contacts

Public ContactKomalpreet Kaur

University College Of Nursing BFUHS faridkot

prekshamaheshwari@gmail.com9478964460

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026